Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1904183

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1904183

Diabetes Device Market Size, Share, and Growth Analysis, By Type (BGM Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Diabetes Device Market size was valued at USD 36.23 Billion in 2024 and is poised to grow from USD 39.42 Billion in 2025 to USD 77.4 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global burden of diabetes is intensifying, driven by increasing urbanization and sedentary lifestyles. Currently, a significant population is living with diabetes, which is often linked to serious health complications such as stroke, cardiovascular disease, nerve damage, and infections. This growing awareness of diabetes management emphasizes the necessity for advanced medical devices aimed at effective disease control and complication prevention. Consequently, there is a rising demand for sophisticated insulin delivery systems, including high-end pumps and pens, reflecting a shift towards innovative solutions in diabetes care. Leading manufacturers are strategically focusing on technological advancements and creating groundbreaking products to capture a substantial share of the burgeoning diabetes device market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segments Analysis

Global Diabetes Device Market is segmented by Type, Distribution Channel, End Use and region. Based on Type, the market is segmented into BGM Devices. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Device Market

The increasing global prevalence of diabetes serves as a key catalyst for the expansion of the diabetes device market. A combination of factors, including sedentary lifestyles, poor dietary choices, rising obesity rates, and an aging demographic, is fueling the surge in diabetes cases. This growing incidence elevates the necessity for advanced diabetes devices designed for effective management and monitoring of the condition. As more individuals seek solutions to control their diabetes, the demand for innovative devices continues to rise, driving market growth and prompting manufacturers to develop technologies that cater to this pressing healthcare challenge.

Restraints in the Global Diabetes Device Market

The effectiveness of diabetes management heavily relies on the accuracy and reliability of diabetes devices. Unfortunately, variations in measurements, calibration challenges, or technical malfunctions can sometimes occur, undermining the dependability of the data these devices provide. Such inaccuracies can result in misguided treatment decisions, potentially jeopardizing patient safety. To foster confidence among healthcare professionals and those living with diabetes, it is imperative that manufacturers prioritize the consistent accuracy and reliability of their devices. Enhancing these factors not only supports effective treatment but also strengthens the overall trust in diabetes management tools within the healthcare ecosystem.

Market Trends of the Global Diabetes Device Market

The Global Diabetes Device market is experiencing a notable trend toward the integration of advanced technology in insulin delivery systems, particularly through innovations in insulin pumps and pens. The emergence of smart insulin delivery systems, which seamlessly connect with continuous glucose monitoring (CGM) systems, is revolutionizing diabetes management. These sophisticated devices facilitate automated insulin adjustments based on real-time glucose readings, enhancing user convenience and accuracy. As a result, patients benefit from personalized insulin delivery, leading to improved glycaemic control and overall health outcomes. This technological evolution underscores the growing demand for smarter, more interconnected diabetes management solutions in the market.

Product Code: SQMIG35B2125

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Diabetes Device Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • BGM Devices
    • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
    • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
    • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Global Diabetes Device Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

Global Diabetes Device Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Diagnostic Centers
  • Homecare

Global Diabetes Device Market Size & CAGR (2026-2033)

  • North America (Type, Distribution Channel, End Use)
    • US
    • Canada
  • Europe (Type, Distribution Channel, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Distribution Channel, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Distribution Channel, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Distribution Channel, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DexCom (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tandem Diabetes Care (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeScan (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AgaMatrix Holdings (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARKRAY USA (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!